Catalyst Funds Management Pty Ltd Takes Position in Revvity Inc. $RVTY

Catalyst Funds Management Pty Ltd bought a new position in shares of Revvity Inc. (NYSE:RVTY) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 16,500 shares of the company’s stock, valued at approximately $1,596,000.

A number of other large investors have also bought and sold shares of the stock. Jefferies Financial Group Inc. bought a new stake in Revvity in the fourth quarter valued at $1,170,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Revvity during the 4th quarter worth about $339,000. Diamond Hill Capital Management Inc. grew its stake in shares of Revvity by 6.3% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock valued at $41,302,000 after buying an additional 25,233 shares during the period. Covestor Ltd increased its position in Revvity by 78.3% in the 4th quarter. Covestor Ltd now owns 815 shares of the company’s stock valued at $79,000 after buying an additional 358 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in Revvity by 18.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 37,079 shares of the company’s stock worth $3,587,000 after buying an additional 5,881 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Trading Up 1.6%

NYSE RVTY opened at $96.93 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $90.69 and a 200 day simple moving average of $96.96. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The firm has a market capitalization of $10.81 billion, a P/E ratio of 46.38, a PEG ratio of 2.09 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same period in the previous year, the firm earned $1.01 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, analysts predict that Revvity Inc. will post 5.33 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio is presently 13.40%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Jefferies Financial Group raised their price objective on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Stifel Nicolaus reduced their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research report on Wednesday, May 6th. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Wells Fargo & Company lifted their price objective on shares of Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Finally, TD Cowen upped their target price on shares of Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.